Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Paclitaxel Dcb

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed2
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT05450042Not ApplicableUnknown

Vascular Effects Through Sirolimus vs. Paclitaxel DCB Implantation

NCT01041365Completed

Vitamin D, Insulin Sensitivity, and Vascular Associations in Adolescents

NCT01041547Completed

Vascular Function, Insulin Sensitivity, and Vitamin D

Showing all 3 trials

Research Network

Common Treatments

  • Paclitaxel Dcb1
  • Selution Slr Dcb1

Active Sponsors

  • University of Alabama at Birmingham2
  • University Hospital, Essen1

Top Investigators

Related Conditions

  • Insulin Sensitivity2
  • Arterial Stiffness2
  • Drug Eluting Balloon1
  • Infrainguinal Peripheral Arterial Disease1
  • Peripheral Arterial Disease1

Activity Timeline